Franklin Genomic Advancements ETF Rating $30.08 +0.01 (+0.04%) Closing price 02/21/2025 03:55 PM EasternExtended Trading$30.08 0.00 (0.00%) As of 02/21/2025 05:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatings Franklin Genomic Advancements ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.HELX Aggregate RatingModerate Buy 2.76Holdings in HELX have an aggregate rating of Moderate Buy based on 638 analyst ratings issued in the past year covering 45 companies (86.5% of the portfolio).HELX Aggregate Price Target$30.09High Prediction$30.09Average Prediction$30.09Low Prediction$30.09Holdings in HELX have an aggregate price target of $30.09 and a range of $30.09 to $30.09 covering 45 companies (86.5% of the portfolio).HELX Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy7 Buy rating(s)Moderate Buy32 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Franklin Genomic Advancements ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 45 HELX Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings6.11%NTRANatera$162.31-3.5%2.5818 of 5 stars3.00$170.94 5.3%16Positive News4.26%VRTXVertex Pharmaceuticals$484.24+0.8%4.1184 of 5 stars2.65$505.61 4.4%26Analyst DowngradeInsider TradeAnalyst RevisionPositive News3.93%KRYSKrystal Biotech$187.86+2.9%4.4894 of 5 stars3.00$210.00 11.8%8Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage3.62%UTHRUnited Therapeutics$361.10-1.7%4.3677 of 5 stars2.67$388.25 7.5%12Insider TradePositive News3.59%REGNRegeneron Pharmaceuticals$700.33+0.6%4.7635 of 5 stars2.76$973.13 39.0%25Dividend Announcement3.52%MEDPMedpace$340.78-1.2%4.2604 of 5 stars2.45$381.44 11.9%113.36%LLYEli Lilly and Company$874.12+0.1%4.8481 of 5 stars2.85$1,007.94 15.3%20Positive News3.31%TMOThermo Fisher Scientific$532.55-1.0%4.7385 of 5 stars2.82$658.00 23.6%22Dividend IncreaseAnalyst RevisionPositive News2.79%BNTXBioNTech$120.01+1.8%2.4325 of 5 stars2.88$142.72 18.9%17Positive NewsHigh Trading Volume2.76%AZNAstraZeneca$74.20-0.5%2.6822 of 5 stars3.10$89.75 21.0%10Options Volume2.58%CTVACorteva$62.75-1.7%4.4898 of 5 stars2.67$67.73 7.9%18News CoveragePositive News2.44%INSMInsmed$81.06-3.0%4.0378 of 5 stars3.00$91.00 12.3%15Earnings ReportAnalyst ForecastInsider TradeAnalyst RevisionNews Coverage2.42%SRPTSarepta Therapeutics$106.28-2.0%4.5034 of 5 stars2.87$176.77 66.3%23Upcoming Earnings2.26%TWSTTwist Bioscience$41.31-8.4%4.6007 of 5 stars2.70$53.80 30.2%10Positive News2.12%RAREUltragenyx Pharmaceutical$42.59-4.2%4.6248 of 5 stars2.93$93.50 119.5%14Analyst Forecast2.03%CDNSCadence Design Systems$258.27-4.4%4.919 of 5 stars2.75$326.92 26.6%12Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageHigh Trading Volume2.03%ALNYAlnylam Pharmaceuticals$250.59-0.2%4.4472 of 5 stars2.72$299.48 19.5%25Analyst ForecastInsider Trade2.02%DHRDanaher$209.86+0.9%4.992 of 5 stars2.71$278.00 32.5%21Dividend IncreaseAnalyst RevisionPositive News1.95%GHGuardant Health$42.87-9.6%4.2167 of 5 stars3.00$44.78 4.5%18Earnings ReportAnalyst ForecastNews CoverageGap UpHigh Trading Volume1.92%RVTYRevvity$113.72-0.9%4.1155 of 5 stars2.77$136.25 19.8%13Positive News1.88%EXASExact Sciences$49.26-0.5%4.6888 of 5 stars2.95$72.06 46.3%19Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage1.50%TEMTempus AI$68.09-11.2%1.387 of 5 stars2.67$58.55 -14.0%12Insider TradeGap Up1.46%LGNDLigand Pharmaceuticals$120.56-1.2%4.1424 of 5 stars3.00$147.00 21.9%6Positive News1.43%AAgilent Technologies$135.33-1.1%4.0902 of 5 stars2.50$144.38 6.7%14Upcoming EarningsDividend AnnouncementNews CoveragePositive News1.38%QGENQiagen$39.52+2.5%4.4452 of 5 stars2.30$47.71 20.7%10Analyst Downgrade1.37%BBIOBridgeBio Pharma$36.85+0.1%4.8248 of 5 stars2.92$51.67 40.2%13Earnings ReportAnalyst ForecastInsider TradeNews Coverage1.30%RGENRepligen$158.99-2.3%4.4474 of 5 stars2.62$181.00 13.8%13Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage1.25%CRLCharles River Laboratories International$163.11+0.5%4.7854 of 5 stars1.88$195.71 20.0%16Earnings ReportAnalyst ForecastInsider TradeAnalyst RevisionNews Coverage1.17%LHLaboratory Co. of America$249.86+0.3%4.7715 of 5 stars2.88$265.31 6.2%16Positive News1.16%RXRXRecursion Pharmaceuticals$9.28-10.3%1.5106 of 5 stars2.50$8.75 -5.7%41.10%BIOBio-Rad Laboratories$279.48-2.2%4.8057 of 5 stars2.60$395.20 41.4%51.09%BEAMBeam Therapeutics$30.43-8.2%3.1351 of 5 stars3.00$47.67 56.6%12Gap Up1.08%BMRNBioMarin Pharmaceutical$68.25-0.7%4.9188 of 5 stars2.70$93.81 37.4%23Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage1.03%IQVIQVIA$190.94-1.6%4.962 of 5 stars2.90$251.22 31.6%21Analyst ForecastPositive News1.02%DOCSDoximity$72.25-3.7%2.5869 of 5 stars2.57$64.22 -11.1%211.01%NBIXNeurocrine Biosciences$120.69+3.9%4.9803 of 5 stars2.83$166.90 38.3%23Analyst DowngradeBuyback AnnouncementAnalyst RevisionGap Up1.00%ADPTAdaptive Biotechnologies$8.27-0.7%3.6503 of 5 stars2.80$9.10 10.0%5Analyst ForecastInsider Trade0.96%VCYTVeracyte$39.18-4.6%2.9234 of 5 stars2.67$42.00 7.2%9Analyst DowngradeNews Coverage0.96%AZTAAzenta$44.75-0.1%3.5137 of 5 stars2.50$58.75 31.3%4Positive News0.95%BRKRBruker$50.82-4.0%4.8618 of 5 stars2.55$70.50 38.7%110.94%TECHBio-Techne$64.92-0.9%4.9262 of 5 stars2.50$84.29 29.8%8Analyst DowngradeInsider Trade0.75%GRALGrail$40.73-14.7%1.0044 of 5 stars2.00$16.00 -60.7%3Earnings ReportNews CoverageGap Up0.70%IONSIonis Pharmaceuticals$32.33-1.1%4.4322 of 5 stars2.70$60.00 85.6%20Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage0.51%AREAlexandria Real Estate Equities$95.59+0.1%4.691 of 5 stars2.18$121.30 26.9%11Analyst DowngradeAnalyst RevisionNews Coverage0.51%DVAXDynavax Technologies$13.334.2783 of 5 stars2.33$21.50 61.3%3Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageGap Up This page (BATS:HELX) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersEx-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000”Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. ...Colonial Metals | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Franklin Genomic Advancements ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Franklin Genomic Advancements ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HELX Stock Alerts